The Revised FIGO Staging System for Uterine Malignancies: Implications for MR Imaging
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Cancers of the uterine corpus and cervix are the most common gynecologic malignancies worldwide. The International Federation of Gynecology and Obstetrics (FIGO) staging system was first established in 1958, when it was recognized that the recurrence rate and patient outcomes were directly related to the degree of tumor spread at the patient's initial presentation. Changes in understanding of tumor biology led to a recent update in the FIGO staging system that reflects the variation in treatment strategies between endometrial and cervical cancer. Patients with endometrial cancer are primarily treated with hysterectomy; thus, staging is done at surgery and histologic analysis. Magnetic resonance (MR) imaging may accurately depict the extent of endometrial cancer at diagnosis and, in conjunction with the tumor grade and histologic subtype, help stratify risk, which determines the therapeutic course. Cervical carcinoma is staged at clinical examination because many tumors are inoperable at the time of patient presentation. Preoperative MR imaging criteria are not formally included in the revised FIGO staging system because cervical carcinoma is most prevalent in developing countries, where imaging resources are limited. However, MR imaging is highly sensitive and specific for depicting important prognostic factors and, when available, is recommended as an adjunct to clinical examination. The MR imaging findings of uterine carcinoma should be discussed in a multidisciplinary setting in conjunction with clinical and histologic findings, an approach that provides accurate staging and risk stratification and allows for individualized treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
Pecorelli, S. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.02.012 · Cited by 2,881 · cited 1×
“Third, examinations performed with anesthesia, including cystoscopy and proctoscopy, are optional and no longer mandatory, a change from the 1988 FIGO staging system (78).”
MethodDiffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
Koh, D.-M., & Collins, D. J. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1403 · Cited by 1,993 · cited 1×
“DWI is a physiologic imaging technique that provides information about water mobility, tissue cellularity, and the integrity of cellular membranes (39,41,42).”
Background(2009) · The Lancet · doi:10.1016/s0140-6736(08)61766-3 · Cited by 1,801 · cited 1×
“4% in those with low risk to 9% in those with intermediate risk and 24% in those with high risk (7,9).”
BackgroundCreutzberg, C. L., van Putten, W. L., Koper, P. C., Lybeert, M. L., Jobsen, J. J., Wárlám-Rodenhuis, C. C., De Winter, K. A., Lutgens, L. C., van den Bergh, A. C., van de Steen-Banasik, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02139-5 · Cited by 1,773
Panici, P. B., Basile, S., Maneschi, F., Lissoni, A. A., Signorelli, M., Scambia, G., Angioli, R., Tateo, S., Mangili, G., Katsaros, D., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn397 · Cited by 1,544 · cited 2×
“(7) Stage IIIC1 endometrial carcinoma (high-grade serous carcinoma) in a 75-year-old woman.”
BackgroundBreast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Forouzanfar, M. H., Foreman, K. J., Delossantos, A. M., Lozano, R., Lopez, A. D., Murray, C. J. L., & Naghavi, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61351-2 · Cited by 1,009 · cited 2×
“In contrast, although cervical cancer is the third most common gynecologic malignancy in the United States, it remains the most common gynecologic malignancy worldwide (11,12).”
BackgroundTodo, Y., Kato, H., Kaneuchi, M., Watari, H., Takeda, M., & Sakuragi, N. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62002-x · Cited by 859 · cited 1×
“However, if suspicious lymph nodes are seen preoperatively or in the presence of a high-grade, high-stage tumor at MR imaging, lymph node dissection may be considered (10).”
BackgroundEndometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., & Sessa, C. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr374 · Cited by 574 · cited 2×
“The mean age at presentation is 63 years, and more than 90% of patients are women over the age of 50 years (45).”
BackgroundBipat, S., Glas, A. S., Velden, J. V. D., Zwinderman, A. H., Bossuyt, P. M. M., & Stoker, J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00409-8 · Cited by 393 · cited 1×
“However, T2-weighted MR imaging accurately depicts bladder (sensitivity, 75%) and rectal (sensitivity, 71%) involvement (79).”
Background
Metadata
- Authors
- Freeman, S. J., Aly, A. M., Kataoka, M. Y., Addley, H. C., Reinhold, C., & Sala, E.
- Venue
- RadioGraphics
- Published
- 2012-10
- Volume
- 32
- Issue
- 6
- Pages
- 1805-1827
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2099106749
- Cited by
- 197
- References
- 33
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Revised FIGO Staging System for Uterine Malignancies: Implications for MR Imaging. https://app.cochat.ai/papers/10.1148/rg.326125519
- The paper
- Freeman, S. J., Aly, A. M., Kataoka, M. Y., Addley, H. C., Reinhold, C., & Sala, E. (2012). The Revised FIGO Staging System for Uterine Malignancies: Implications for MR Imaging. RadioGraphics. https://doi.org/10.1148/rg.326125519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.